YOU ARE DOWNLOADING DOCUMENT

Please tick the box to continue:

Transcript
Page 1: Pembrolizumab vrs. ipilimumab

Dr. Hugo CastroDr, Julio Herol de León

Guatemala, 28 agosto de 2015

Page 2: Pembrolizumab vrs. ipilimumab
Page 3: Pembrolizumab vrs. ipilimumab
Page 4: Pembrolizumab vrs. ipilimumab
Page 5: Pembrolizumab vrs. ipilimumab

Métodos

• Inclusión

• Exclusión

Page 6: Pembrolizumab vrs. ipilimumab
Page 7: Pembrolizumab vrs. ipilimumab
Page 8: Pembrolizumab vrs. ipilimumab
Page 9: Pembrolizumab vrs. ipilimumab
Page 10: Pembrolizumab vrs. ipilimumab
Page 11: Pembrolizumab vrs. ipilimumab
Page 12: Pembrolizumab vrs. ipilimumab
Page 13: Pembrolizumab vrs. ipilimumab
Page 14: Pembrolizumab vrs. ipilimumab
Page 15: Pembrolizumab vrs. ipilimumab
Page 16: Pembrolizumab vrs. ipilimumab
Page 17: Pembrolizumab vrs. ipilimumab
Page 18: Pembrolizumab vrs. ipilimumab
Page 19: Pembrolizumab vrs. ipilimumab
Page 20: Pembrolizumab vrs. ipilimumab
Page 21: Pembrolizumab vrs. ipilimumab

Related Documents